Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
Yomelela
1 other identifier
interventional
3,771
1 country
2
Brief Summary
Retention in care and persistent adherence to antiretroviral therapy are necessary for the successful treatment of HIV infection. HIV-related stigma is a known impediment to the care and health outcomes of people living with HIV. The proposed study will test theory-based interventions designed to manage HIV stigma in order to improve care retention and medication adherence in communities with high-levels of HIV-related stigma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 15, 2021
CompletedFirst Posted
Study publicly available on registry
November 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
August 29, 2025
August 1, 2025
5.3 years
October 15, 2021
August 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Medical Records of Care Appointments
Medical records are retrospectively collected for all scheduled care visits and coded for whether the visits were attended.The records are exclusively from the clinic where patients are initially recruited and with patient permission. The data obtained are expressed as the ratio of the number of care appointments attended relative to the number scheduled.
12-months
Blood Plasma RNA
Collection of dried blood spots are tested for HIV RNA (viral load) using PCR tests with results expressed as the number of RNA copies per mL of blood plasma.
12-months
Secondary Outcomes (1)
Antiretroviral Medication Adherence
12-months
Study Arms (3)
Uniform Standard of Care Counseling
PLACEBO COMPARATORRoutine HIV counseling services available to patients with protocol delivered services. Three sessions of patient education monitored for protocol adherence.
Behavioral Self-Regulation Skills Counseling
ACTIVE COMPARATORMobile phone-delivered counseling grounded in Behavioral Self- Regulation Theory to improve retention in HIV care and HIV viral suppression. Counseling is delivered by lay counselors in differentiated health care context. This is a culturally tailored adaptation of CDC disseminated Phone-Delivered Support Counseling for HIV treatment Adherence.
Behavioral Self-Regulation Skills Counseling + Stigma Management
EXPERIMENTALMobile phone-delivered counseling grounded in Behavioral Self- Regulation Theory with stigma management to improve retention in HIV care and HIV viral suppression. Counseling is delivered by lay counselors in differentiated health care context with added components directly targeting stigma-related experiences and concerns.
Interventions
Routine HIV counseling services available to patients with protocol delivered services. Three sessions of patient education monitored for protocol adherence
Mobile phone-delivered counseling grounded in Behavioral Self- Regulation Theory to improve retention in HIV care and HIV viral suppression. Counseling is delivered by lay counselors in differentiated health care context. This is a culturally tailored adaptation of CDC disseminated Phone-Delivered Support Counseling for HIV treatment Adherence.
Mobile phone-delivered counseling grounded in Behavioral Self- Regulation Theory with stigma management to improve retention in HIV care and HIV viral suppression. Counseling is delivered by lay counselors in differentiated health care context with added components directly targeting stigma-related experiences and concerns.
Eligibility Criteria
You may qualify if:
- years of age or older
- current clinic visit to receive cART in differentiated care outside of an adherence club
- unsuppressed HIV at the most recent clinical testing confirmed in run-in
- access to a phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Connecticutlead
- Medical Research Council, South Africacollaborator
Study Sites (2)
University of Connecticut
Storrs, Connecticut, 06269, United States
University of Connecticut Field Site
Atlanta, Georgia, 30308, United States
Related Publications (1)
Kalichman SC, Mathews C, Banas E, Kalichman MO. Stigma management intervention to improve antiretroviral therapy adherence: Phase-I test of concept trial, Cape Town South Africa. Glob Public Health. 2019 Aug;14(8):1059-1074. doi: 10.1080/17441692.2018.1552307. Epub 2018 Nov 30.
PMID: 30500309BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Study condition masking
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2021
First Posted
November 8, 2021
Study Start
February 1, 2021
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
August 29, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share